Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Shares Issued (2018 - 2025)

SRx Health Solutions (SRXH) has disclosed Shares Issued for 10 consecutive years, with $9.2 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Shares Issued changed N/A year-over-year to $9.2 million, compared with a TTM value of $9.9 million through Jun 2025, changed N/A, and an annual FY2021 reading of $36.1 million, up 3343.23% over the prior year.
  • Shares Issued was $9.2 million for Q2 2025 at SRx Health Solutions, up from $674000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $32.1 million in Q4 2021 and bottomed at $400000.0 in Q2 2021.
  • Average Shares Issued over 3 years is $7.7 million, with a median of $1.8 million recorded in 2021.
  • Peak annual rise in Shares Issued hit 2960.4% in 2021, while the deepest fall reached 2960.4% in 2021.
  • Year by year, Shares Issued stood at $32.1 million in 2021, then plummeted by 97.9% to $674000.0 in 2024, then soared by 1270.62% to $9.2 million in 2025.
  • Business Quant data shows Shares Issued for SRXH at $9.2 million in Q2 2025, $674000.0 in Q4 2024, and $32.1 million in Q4 2021.